New York, Feb 4, 2026, 14:05 EST — Regular session
CoreWeave shares dropped roughly 8.5% to $82.40 in afternoon trade, hitting a session low of $82.11. A new round of selling pressure battered high-growth tech stocks. By mid-afternoon, volume reached around 17.7 million shares.
This matters since CoreWeave has emerged as a key indicator of appetite for “AI infrastructure” risk — a stock that often plunges quickly when traders pull back from pricey growth bets, then rebounds sharply when sentiment turns.
Selling this week has been driven by fresh worries over how fast AI tools might undercut software and data firms, alongside a rush to revalue their potential earnings a few years down the line. “We are not yet at the point where AI agents will destroy software companies,” said Ben Barringer, head of technology research at Quilter Cheviot. Nvidia CEO Jensen Huang dismissed the notion as “illogical,” Reuters reported. Reuters
CoreWeave dropped Wednesday following a roughly 17% plunge in chipmaker AMD and a more than 2% slide in the Nasdaq, dragging other AI-related stocks lower.
CoreWeave, a provider of GPU-intensive cloud capacity for AI model development, has shown a wide beta tied to the sector’s volatility. When chip stocks slide and chatter shifts from “AI spending” to “AI disruption,” this name usually takes a hit.
Two Form 144 filings accepted on Feb. 2 revealed that entities linked to officer Brannin McBee intend to sell CoreWeave common stock. CANIS MINOR 2025 FAMILY TRUST LLC registered 1,000 shares—valued at roughly $93,190 when filed—while CANIS MINOR 2025 GRAT listed 8,335 shares, worth about $776,739. Both sales are set to go through Morgan Stanley Smith Barney as the broker.
Form 144 signals proposed sales under Rule 144, a U.S. securities regulation that governs the resale of restricted and “control” stock owned by affiliates. While it indicates possible supply entering the market, it doesn’t guarantee that the shares will actually be sold.
Some investors are also watching a growing legal drumbeat around the company. On Wednesday, Hagens Berman announced it was probing claims against CoreWeave related to alleged data-center delays and disclosure risks.
That combination — macro selling, chip sector volatility, and a constant flow of insider-sale filings — can magnify swings in a stock that already moves like a leveraged play on AI expansion.
CoreWeave’s upcoming earnings report is set for Feb. 18, according to Investing.com. Investors will be focused on any shifts in delivery schedules, capital expenditure plans, and whether demand remains strong amid changing AI market forecasts.
